Monday 18 February 2019
Home      All news      Contact us      India
in.reuters.com - 6 days ago

U.S. FDA panel recommends approval of Johnson Johnson s depression drug

An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended Johnson Johnson s experimental nasal spray, which has a compound similar to often-abused ketamine, for patients suffering from depression.

Related news

Latest News
Hashtags:   

panel

 | 

recommends

 | 

approval

 | 

Johnson

 | 

Johnson

 | 

depression

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources